Our findings suggested the possibility, without confirmation, that exposure to bile acid sequestrants targeting ABCG5/ABCG8, cholesterol absorption inhibitors targeting NPC1L1, and Mipomersen targeting APOB might increase the likelihood of migraines in individuals. The gene discussed is APOB; the disease is migraine disorder.